Fund Manager Focus: Trump signals Big Pharma shake-up – with Ketan Patel of EdenTree

The pharmaceutical industry is set for massive regulatory change in the US, with Trump revealing his plans to scrap most of the Food and Drug Administration’s regulations. Although this could be beneficial for investors in pharmaceutical companies, critics have claimed the removal of some regulations could put consumers and patients at risk. Ketan Patel, fund manager at EdenTree discusses this issue with Share Radio. Listen again here: